As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
September 29, 2023 at 10:20 AM EDT
A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|